Retrospective evaluation of a possible interaction between warfarin and levofloxacin

Pharmacotherapy

Volumn 25, Issue 1, 2005, Pages 67-73

  McCall, Kenneth L ^a   Scott, John C ^a   Anderson Jr , H Glenn ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Anticoagulant therapy; Drug interaction; Felodipine; INR; International normalized ratio; Levofloxacin; Warfarin

Indexed keywords

FELODIPINE; LEVOFLOXACIN; WARFARIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ANTICOAGULATION; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG CROSS REACTIVITY; EVALUATION; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LONG TERM EXPOSURE; MALE; MEDICAL RECORD; OUTCOMES RESEARCH; OUTPATIENT; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

AGED; BODY TEMPERATURE; DATA COLLECTION; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FELODIPINE; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MEDICAL RECORDS; MIDDLE AGED; OFLOXACIN; OUTPATIENTS; PRESCRIPTIONS, DRUG; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; WARFARIN;

EID: 11144223568     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.25.1.67.55624     Document Type: Article

References (18)

1. Hirsh J, Dalen JE, Anderson DR, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 2001;119(suppl 1):8S-21.
2. Ansell JE, Hirsh J, Dalen JE, et al. Managing oral anticoagulant therapy. Chest 2001;119(suppl 1):22S-38.
3. Udall JA. Human sources and absorption of vitamin K in relation to anticoagulation. JAMA 1965;194:127-9.
4. O'Reilly RA. Stereoselective interaction of trimethoprimsulfamethoxazole with the separated enantiomorphs of racemic warfarin in man. N Engl J Med 1980;302:33-5.
5. Israel DS, Stotka J, Rock W, et al. Effect of ciprofloxacin on the pharmacokinetics and pharmacodynamics of warfarin. Clin Infect Dis 1996;22:251-6.
6. Okazaki O, Kojima C, Hakusui H, et al. Enantioselective disposition of ofloxacin in humans. Antimicrob Agents Chemother 1991;35:2106-9.
7. Fish D, Chow A. The clinical pharmacokinetics of levofloxacin. Clin Pharmacokinet 1997;32:101-19.
8. Liao S, Palmer M, Fowler C, Nayak RK. Absence of an effect of levofloxacin on warfarin pharmacokinetics and anticoagulation in male volunteers. J Clin Pharmacol 1996;36:1072-7.
9. Ortho-McNeil Pharmaceutical, Inc. Levaquin (levofloxacin) prescribing information. Raritan, NJ; 2002.
10. Gheno G, Cinetto L. Levofloxacin-warfarin interaction [letter]. Eur J Clin Pharmacol 2001;57:427.
11. Ravnan SL, Locke C. Levofloxacin and warfarin interaction. Pharmacotherapy 2001;21:884-5.
12. Jones CB, Fugate SE. Levofloxacin and warfarin interaction. Ann Pharmacother 2002;36:1554-7.
13. Yamreudeewong W, Lower DL, Kilpatrick DM, Enlow AM, Burrows MM, Greenwood MC. Effect of levofloxacin coadministration on the international normalized ratios during warfarin therapy. Pharmacotherapy 2003;23:333-8.
14. Grind M, Murphy M, Warrington S, Åberg J. Method for studying drug-warfarin interactions. Clin Pharmacol Ther 1993;54:381-7.
15. College of American Pathologists. College of American Pathologists laboratory accreditation program manual, May 2003 ed. Available from http://www.cap.org/apps/docs/ laboratory_accreditation/standards/lapmanual_0503. pdf. Accessed August 3, 2003.
16. Beckey NP, Parra D, Colon A. Retrospective evaluation of a potential interaction between azithromycin and warfarin in patients stabilized on warfarin. Pharmacotherapy 2000;20(9): 1055-9.
17. McCall KL, Anderson HG, Jones AD. Determination of the lack of a drug interaction between azithromycin and warfarin. Pharmacotherapy 2004;24(2):188-94.
18. Glasheen JJ, Fugit RV, Prochazka AV. Effect of levofloxacin coadministration on the international normalized ratios during warfarin therapy-a comment [letter]. Pharmacotherapy 2003;23(8):1079-80.